- Report
- January 2026
Global
From €6764EUR$7,500USD£5,800GBP
- Clinical Trials
- December 2025
- 130 Pages
Global
From €3111EUR$3,450USD£2,668GBP
- Report
- November 2025
- 72 Pages
Global
From €16229EUR$17,995USD£13,916GBP
- Clinical Trials
- November 2025
- 2015 Pages
Global
From €3111EUR$3,450USD£2,668GBP
- Clinical Trials
- November 2025
- 68 Pages
Global
From €3111EUR$3,450USD£2,668GBP
- Clinical Trials
- October 2025
- 807 Pages
Global
From €3111EUR$3,450USD£2,668GBP
- Report
- October 2025
- 88 Pages
Global
From €3152EUR$3,495USD£2,703GBP
- Clinical Trials
- September 2025
- 855 Pages
Global
From €3111EUR$3,450USD£2,668GBP
- Report
- July 2026
- 77 Pages
Global
From €3152EUR$3,495USD£2,703GBP
- Report
- June 2026
- 120 Pages
Global
From €3152EUR$3,495USD£2,703GBP
- Report
- June 2026
- 108 Pages
Global
From €9014EUR$9,995USD£7,730GBP
- Report
- June 2026
- 53 Pages
Global
From €9014EUR$9,995USD£7,730GBP
- Report
- June 2026
- 50 Pages
Global
From €9014EUR$9,995USD£7,730GBP
- Report
- May 2026
- 100 Pages
Global
From €3152EUR$3,495USD£2,703GBP
- Report
- May 2026
- 53 Pages
Global
From €3111EUR$3,450USD£2,668GBP
- Clinical Trials
- April 2026
- 584 Pages
Global
From €3111EUR$3,450USD£2,668GBP
- Clinical Trials
- April 2026
- 427 Pages
Global
From €3111EUR$3,450USD£2,668GBP
- Clinical Trials
- April 2026
- 269 Pages
Global
From €3111EUR$3,450USD£2,668GBP
- Report
- March 2026
- 177 Pages
Global
From €16229EUR$17,995USD£13,916GBP
- Report
- March 2026
- 58 Pages
Global
From €9014EUR$9,995USD£7,730GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more